Logo Logo
Hilfe
Hilfe
Switch Language to English

Kennedy, James T.; Wisch, Julie K. ORCID logoORCID: https://orcid.org/0000-0003-3624-2784; Boerwinkle, Anna H.; Millar, Peter R.; McKay, Nicole S.; Brickman, Adam M. ORCID logoORCID: https://orcid.org/0000-0002-5125-8226; Chhatwal, Jasmeer P. ORCID logoORCID: https://orcid.org/0000-0002-7792-1698; Mendez, Patricio Chrem; Christian, Bradley T. ORCID logoORCID: https://orcid.org/0000-0002-9653-559X; Cohen, Anne; Cruchaga, Carlos ORCID logoORCID: https://orcid.org/0000-0002-0276-2899; Daniels, Alisha; Flores, Shaney; Handen, Benjamin L.; Hartley, Sigan L.; Head, Elizabeth ORCID logoORCID: https://orcid.org/0000-0003-1115-6396; Ibanez, Laura; Krisnsky‐McHale, Sharon J.; Fougere, Christian la; Lai, Florence; Laymon, Charles M.; Lee, Joseph H.; Lee, Jae‐Hong; Levin, Johannes ORCID logoORCID: https://orcid.org/0000-0001-5092-4306; Llibre‐Guerra, Jorge; Aguillon, David F.; Lott, Ira T.; Mapstone, Mark; McDade, Eric M. ORCID logoORCID: https://orcid.org/0000-0002-6764-3866; Morris, John C. ORCID logoORCID: https://orcid.org/0000-0001-9820-5618; O'Bryant, Sid E.; Price, Julie C.; Rafii, Michael S.; Roh, Jee Hoon ORCID logoORCID: https://orcid.org/0000-0002-3243-0529; Rosas, H. Diana; Schupf, Nicole; Supnet‐Bell, Charlene; Xiong, Chengjie; Zaman, Shahid; Benzinger, Tammie L. S.; Gordon, Brian A. ORCID logoORCID: https://orcid.org/0000-0003-2109-2955 und Ances, Beau M. (2026): Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's disease. In: Alzheimer's & Dementia, Bd. 22, Nr. 1, e71103 [PDF, 4MB]

[thumbnail of Alzheimer_s___Dementia_-_2026_-_Kennedy_-_Brain_volume_trajectories_in_Down_syndrome_and_autosomal_dominant_Alzheimer_s.pdf]
Vorschau
Creative Commons: Namensnennung 4.0 (CC-BY)
Veröffentlichte Version

Abstract

INTRODUCTION:

It is unknown if neurodegeneration trajectories differ between Down syndrome (DS) and autosomal dominant Alzheimer’s disease (ADAD), both ofwhich are genetic forms of Alzheimer’s disease (AD).

METHODS:

We compared brain volumes in DS, ADAD, and unaffected family members serving as controls. Participants underwent magnetic resonance imaging (MRI) and amyloid positron emission tomography (PET), deriving volumetric and amyloid burden, respectively. Nonlinear associations between regional volumes and estimated years to clinical symptom onset (EYO) were evaluated using generalized additive mixed-models.

RESULTS:

Longitudinal data from 267 controls, 341 participants with DS, and 358 participants with ADAD were included, totaling 1908 scans. DS volumes were lower than ADAD and controls initially and dropped linearly. ADAD had similar volumes to controls until diverging, beginning at EYO -7. Amyloid was negatively associated with volume, with similar slopes in DS and ADAD.

DISCUSSION:

ADAD and DS demonstrate distinct patterns of brain volume decline prior to symptom onset despite being similarly affected by amyloid.

Dokument bearbeiten Dokument bearbeiten